It's time to kill the patient COVID-19 tax

It's time to kill the patient COVID-19 tax
Illustration Credit: Greg Groesch/Washington Times

More than 30 million Americans are now unemployed. These folks need all the help our nation can offer. Yet, disturbingly, the Trump administration just finalized a rule that will dramatically spike pharmacy costs. 

The rule allows insurers to disregard manufacturer coupons when calculating patients’ out-of-pocket expenses. This will increase what patients must spend before their insurance kicks in, potentially making critical prescriptions too expensive to fill.

For many Americans, high out-of-pocket costs already drive many to skip needed medicines.

 
Sign Up for Our Email Newsletter

RECENT NEWS

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo...  Read more

The Empty Price Tag

The Empty Price Tag

Why Hospital Price Transparency Has Fallen Short & How Congress Can Make It Right...  Read more

We Can Fight Fraud Without Threatening Access to Care

We Can Fight Fraud Without Threatening Access to Care

When Washington fails to police its own programs, it’s hardworking Americans that pay the price. ...  Read more

DRUGWONKS BLOG